Lpl Financial LLC Galera Therapeutics, Inc. Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.14 - $0.27 $37 - $72	269 Added 1.51%	18,102 $2,000
Q4 2023 Feb 14, 2024	SELL	$0.09 - $0.27 $1,638 - $4,914	-18,200 Reduced 50.51%	17,833 $2,000
Q3 2023 Nov 13, 2023	SELL	$0.17 - $3.0 $204 - $3,606	-1,202 Reduced 3.23%	36,033 $6,000
Q2 2023 Jul 31, 2023	BUY	$2.5 - $3.42 $12,500 - $17,100	5,000 Added 15.51%	37,235 $116,000
Q1 2023 May 10, 2023	BUY	$1.48 - $2.68 $47,707 - $86,389	32,235 New	32,235 $82,000

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.